Islam, E., Elewa, H., & Al-Badriyeh, D. (2022). Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural Management.
Chicago Style (17th ed.) CitationIslam, Eljilany, Hazem Elewa, and Daoud Al-Badriyeh. Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural Management. 2022.
MLA (9th ed.) CitationIslam, Eljilany, et al. Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural Management. 2022.
Warning: These citations may not always be 100% accurate.